ATE448197T1 - Malonamid- und malonsäureamid-ester-derivate mit antithrombotischer wirkung, deren herstellung und verwendung - Google Patents

Malonamid- und malonsäureamid-ester-derivate mit antithrombotischer wirkung, deren herstellung und verwendung

Info

Publication number
ATE448197T1
ATE448197T1 AT01974267T AT01974267T ATE448197T1 AT E448197 T1 ATE448197 T1 AT E448197T1 AT 01974267 T AT01974267 T AT 01974267T AT 01974267 T AT01974267 T AT 01974267T AT E448197 T1 ATE448197 T1 AT E448197T1
Authority
AT
Austria
Prior art keywords
malonamid
production
acid amide
malonic acid
ester derivatives
Prior art date
Application number
AT01974267T
Other languages
English (en)
Inventor
Manfred Schudok
Otmar Klingler
Hans-Peter Nestler
Hans Matter
Herman Schreuder
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE448197T1 publication Critical patent/ATE448197T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/20—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having nitrogen atoms of amidino groups acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01974267T 2000-09-30 2001-09-20 Malonamid- und malonsäureamid-ester-derivate mit antithrombotischer wirkung, deren herstellung und verwendung ATE448197T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121551A EP1193248A1 (de) 2000-09-30 2000-09-30 Malonamid- und Malonsäureamid-ester-Derivate mit antithrombotischer Wirkung, deren Herstellung und Verwendung
PCT/EP2001/010845 WO2002028823A1 (en) 2000-09-30 2001-09-20 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use

Publications (1)

Publication Number Publication Date
ATE448197T1 true ATE448197T1 (de) 2009-11-15

Family

ID=8169996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01974267T ATE448197T1 (de) 2000-09-30 2001-09-20 Malonamid- und malonsäureamid-ester-derivate mit antithrombotischer wirkung, deren herstellung und verwendung

Country Status (12)

Country Link
US (2) US6645992B2 (de)
EP (2) EP1193248A1 (de)
JP (1) JP5016178B2 (de)
AR (1) AR033399A1 (de)
AT (1) ATE448197T1 (de)
AU (2) AU2001293824B2 (de)
CA (1) CA2423857C (de)
DE (1) DE60140478D1 (de)
IL (2) IL155099A0 (de)
MX (1) MXPA03002133A (de)
TW (1) TWI288130B (de)
WO (1) WO2002028823A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1193248A1 (de) * 2000-09-30 2002-04-03 Aventis Pharma Deutschland GmbH Malonamid- und Malonsäureamid-ester-Derivate mit antithrombotischer Wirkung, deren Herstellung und Verwendung
US20040147503A1 (en) * 2002-06-04 2004-07-29 Sheila Zipfeil Novel compounds and compositions as cathepsin inhibitors
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2005282728A1 (en) * 2004-09-03 2006-03-16 Celgene Corporation Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
WO2006101937A1 (en) 2005-03-18 2006-09-28 Janssen Pharmaceutica N.V. Acylhydrazones as kinase modulators
BRPI0808348A2 (pt) * 2007-03-05 2014-07-15 Hoffmann La Roche Aminoamidas como antagonistas de orexina
CA2679985A1 (en) * 2007-03-15 2008-09-18 F. Hoffmann-La Roche Ag Malonamides as orexin antagonists
WO2009007015A1 (en) * 2007-07-10 2009-01-15 Sanofi-Aventis Malonamide derivatives with antithrombotic activity
WO2009105776A1 (en) * 2008-02-21 2009-08-27 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
AU3232597A (en) * 1996-06-18 1998-01-07 Warner-Lambert Company Pyrrolo{1,2-a}pyrazine-1,4-dione serine protease inhibitors
US5859010A (en) * 1996-06-24 1999-01-12 Novo Nordisk A/S Factor VII -binding reagent
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
EP1193248A1 (de) * 2000-09-30 2002-04-03 Aventis Pharma Deutschland GmbH Malonamid- und Malonsäureamid-ester-Derivate mit antithrombotischer Wirkung, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
US7153876B2 (en) 2006-12-26
AU2001293824B2 (en) 2006-01-12
EP1339673A1 (de) 2003-09-03
TWI288130B (en) 2007-10-11
CA2423857C (en) 2010-07-20
US6645992B2 (en) 2003-11-11
EP1339673B1 (de) 2009-11-11
WO2002028823A1 (en) 2002-04-11
JP5016178B2 (ja) 2012-09-05
DE60140478D1 (de) 2009-12-24
JP2004512280A (ja) 2004-04-22
MXPA03002133A (es) 2003-08-19
IL155099A (en) 2008-12-29
IL155099A0 (en) 2003-10-31
CA2423857A1 (en) 2002-04-11
EP1193248A1 (de) 2002-04-03
US20030027828A1 (en) 2003-02-06
AR033399A1 (es) 2003-12-17
AU9382401A (en) 2002-04-15
US20040034027A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
DE69919156D1 (de) Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung
DE60011938D1 (de) Perfluorierte säurefluoride und deren herstellung
DE60113121D1 (de) Herstellung von vernetzter hyaluronsäure und dessen hydrogel, die hergestellten produkte und deren verwendungen
DE50300492D1 (de) Elektroden, deren herstellung und kondensatoren mit diesen elektroden
DE60336907D1 (de) Spirobifluorenderivate, deren herstellung und deren verwendung
EE200200130A (et) Uued farmatseutiliste omadustega aminodikarboksüülhappe derivaadid
DE60233825D1 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
ATE432940T1 (de) Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
DE60202270D1 (de) 4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung
DE60034683D1 (de) 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE69903464D1 (de) Haftverschlüsse, deren herstellung und sie aufweisenden produkten
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
ATE214371T1 (de) 3-hydroxy-pyridin-2-carbonsäureamidester, ihre herstellung und ihre verwendung als arzneimittel
ATE409184T1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
DE60009155D1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE448197T1 (de) Malonamid- und malonsäureamid-ester-derivate mit antithrombotischer wirkung, deren herstellung und verwendung
IS8383A (is) Nýjar afleiður af 4a,5,9,10,11,12-hexahýdróbensófúró[3a,3,2][2]-bensasepín, aðferð við framleiðslu þeirra og notkun þeirra við framleiðslu á lyfjum
DE60200719D1 (de) Filmbildende Zusammensetzung, poröser Film und deren Herstellung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
ATE251170T1 (de) Titanverbindungen, deren herstellung und verwendung
DE60328147D1 (de) Kleine Kupferkugeln und deren Herstellung
DE59006688D1 (de) Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
DE69809091D1 (de) Phenylphosphonsäurederivate und deren Herstellung
DE60228468D1 (de) Kunstzähne und ihre herstellung
DE59203924D1 (de) Substituierte Aminosäureamid-Derivate deren Herstellung und Verwendung als Fungizide.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties